vs
Side-by-side financial comparison of BridgeBio Pharma, Inc. (BBIO) and Latham Group, Inc. (SWIM). Click either name above to swap in a different company.
BridgeBio Pharma, Inc. is the larger business by last-quarter revenue ($154.2M vs $100.0M, roughly 1.5× Latham Group, Inc.). Latham Group, Inc. runs the higher net margin — -7.0% vs -126.2%, a 119.2% gap on every dollar of revenue. On growth, BridgeBio Pharma, Inc. posted the faster year-over-year revenue change (2521.2% vs 14.5%). Latham Group, Inc. produced more free cash flow last quarter ($14.1M vs $-56.5M).
Brent Saunders is an American biopharma executive and entrepreneur who is the chairman and CEO of the health company Bausch & Lomb. He helped lead various mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He founded the special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthet...
Latham & Watkins LLP is an American multinational law firm. Founded in 1934 in Los Angeles, California, it is known for its litigation, corporate, and regulatory law practices.
BBIO vs SWIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $154.2M | $100.0M |
| Net Profit | $-194.6M | $-7.0M |
| Gross Margin | 94.7% | 28.0% |
| Operating Margin | -90.5% | -10.7% |
| Net Margin | -126.2% | -7.0% |
| Revenue YoY | 2521.2% | 14.5% |
| Net Profit YoY | 27.2% | 76.0% |
| EPS (diluted) | $-1.00 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $154.2M | $100.0M | ||
| Q3 25 | $120.7M | $161.9M | ||
| Q2 25 | $110.6M | $172.6M | ||
| Q1 25 | $116.6M | $111.4M | ||
| Q4 24 | — | $87.3M | ||
| Q3 24 | — | $150.5M | ||
| Q2 24 | — | $160.1M | ||
| Q1 24 | $211.1M | $110.6M |
| Q4 25 | $-194.6M | $-7.0M | ||
| Q3 25 | $-184.9M | $8.1M | ||
| Q2 25 | $-183.8M | $16.0M | ||
| Q1 25 | $-169.6M | $-6.0M | ||
| Q4 24 | — | $-29.2M | ||
| Q3 24 | — | $5.9M | ||
| Q2 24 | — | $13.3M | ||
| Q1 24 | $-36.2M | $-7.9M |
| Q4 25 | 94.7% | 28.0% | ||
| Q3 25 | 94.6% | 35.4% | ||
| Q2 25 | 96.7% | 37.1% | ||
| Q1 25 | 97.7% | 29.5% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 32.4% | ||
| Q2 24 | — | 33.1% | ||
| Q1 24 | 99.7% | 27.7% |
| Q4 25 | -90.5% | -10.7% | ||
| Q3 25 | -120.3% | 13.3% | ||
| Q2 25 | -121.4% | 14.3% | ||
| Q1 25 | -89.5% | -4.4% | ||
| Q4 24 | — | -14.9% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | 0.2% | -1.9% |
| Q4 25 | -126.2% | -7.0% | ||
| Q3 25 | -153.2% | 5.0% | ||
| Q2 25 | -166.2% | 9.3% | ||
| Q1 25 | -145.4% | -5.4% | ||
| Q4 24 | — | -33.4% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | -17.1% | -7.1% |
| Q4 25 | $-1.00 | $-0.06 | ||
| Q3 25 | $-0.95 | $0.07 | ||
| Q2 25 | $-0.95 | $0.13 | ||
| Q1 25 | $-0.88 | $-0.05 | ||
| Q4 24 | — | $-0.24 | ||
| Q3 24 | — | $0.05 | ||
| Q2 24 | — | $0.11 | ||
| Q1 24 | $-0.20 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $570.1M | — |
| Total DebtLower is stronger | $2.0B | $279.8M |
| Stockholders' EquityBook value | $-2.1B | $405.9M |
| Total Assets | $936.0M | $823.2M |
| Debt / EquityLower = less leverage | — | 0.69× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $570.1M | — | ||
| Q3 25 | $643.0M | — | ||
| Q2 25 | $756.9M | — | ||
| Q1 25 | $540.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $519.7M | — |
| Q4 25 | $2.0B | $279.8M | ||
| Q3 25 | $2.0B | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | — | $281.5M | ||
| Q3 24 | — | $282.8M | ||
| Q2 24 | — | $282.4M | ||
| Q1 24 | — | $282.8M |
| Q4 25 | $-2.1B | $405.9M | ||
| Q3 25 | $-1.9B | $408.4M | ||
| Q2 25 | $-1.8B | $398.4M | ||
| Q1 25 | $-1.6B | $381.1M | ||
| Q4 24 | — | $387.2M | ||
| Q3 24 | — | $416.6M | ||
| Q2 24 | — | $408.1M | ||
| Q1 24 | $-1.0B | $391.8M |
| Q4 25 | $936.0M | $823.2M | ||
| Q3 25 | $998.3M | $844.4M | ||
| Q2 25 | $1.1B | $822.1M | ||
| Q1 25 | $881.6M | $824.6M | ||
| Q4 24 | — | $794.2M | ||
| Q3 24 | — | $853.4M | ||
| Q2 24 | — | $830.0M | ||
| Q1 24 | $849.3M | $808.6M |
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× | ||
| Q1 24 | — | 0.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-56.4M | $23.3M |
| Free Cash FlowOCF − Capex | $-56.5M | $14.1M |
| FCF MarginFCF / Revenue | -36.6% | 14.1% |
| Capex IntensityCapex / Revenue | 0.0% | 9.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $38.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-56.4M | $23.3M | ||
| Q3 25 | $-109.6M | $51.0M | ||
| Q2 25 | $-80.7M | $36.0M | ||
| Q1 25 | $-199.2M | $-46.9M | ||
| Q4 24 | — | $6.2M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | $52.4M | ||
| Q1 24 | $-219.5M | $-34.5M |
| Q4 25 | $-56.5M | $14.1M | ||
| Q3 25 | $-110.0M | $45.2M | ||
| Q2 25 | $-81.3M | $29.1M | ||
| Q1 25 | — | $-50.3M | ||
| Q4 24 | — | $-98.0K | ||
| Q3 24 | — | $33.2M | ||
| Q2 24 | — | $47.9M | ||
| Q1 24 | $-220.2M | $-39.9M |
| Q4 25 | -36.6% | 14.1% | ||
| Q3 25 | -91.2% | 27.9% | ||
| Q2 25 | -73.5% | 16.8% | ||
| Q1 25 | — | -45.2% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 22.1% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | -104.3% | -36.0% |
| Q4 25 | 0.0% | 9.2% | ||
| Q3 25 | 0.4% | 3.6% | ||
| Q2 25 | 0.5% | 4.0% | ||
| Q1 25 | 0.0% | 3.1% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | 0.3% | 4.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 6.29× | ||
| Q2 25 | — | 2.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.32× | ||
| Q2 24 | — | 3.95× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBIO
Segment breakdown not available.
SWIM
| In Ground Swimming Pools | $50.2M | 50% |
| Covers | $37.0M | 37% |
| Liners | $12.7M | 13% |
